Cannabis Law Report

JUNE 8, 2022

Experienced healthcare leaders bring decades of experience in global drug commercialization and patient access. He previously served as the global CEO for both Sandoz and Alcon, at Novartis Group, where he served on the Executive Committee from 2008 to 2016. Published: Jun 07, 2022.

Therapy 52

Therapy Treatment Access Patients 52

Cannabis Law Report

MARCH 3, 2020

Now, he is the Vice-Chair of Indiana NORML — an organization who is currently focused on changing cannabis laws for the access to Medical Cannabis as therapeutic treatment in Indiana. The findings of anecdotal and controlled studies regarding the efficacy for patient use are mixed. ” CANNABINOID BACKGROUND: .

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Patients benefit from a broad spectrum of cannabis products addressing various medical conditions.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

Veriheal

OCTOBER 1, 2020

In 2004, cannabis was reclassified as a class C drug but was reinstated to Class B in 2008 following Prime Minister Gordon Brown’s decision to go against the advice offered up by the Advisory Council on the Misuse of Drugs. . Cannabis is easily accessible, and the regulations are loosening up quite a bit.

Legalization 104

Legalization Oil Medicine Media 104

The Cannigma

OCTOBER 10, 2021

The report also states that regardless of any changes to the country’s drug policies, there was a “substantial decline in arrests, prosecutions, and convictions for cannabis use,” between 1991 and 2008. What New Zealand’s law permits for medical patients. Who qualifies for medical cannabis in New Zealand if any, and cost/access.

Legalization 67

Legalization Medicine Patients CBD 67

Veriheal

FEBRUARY 28, 2021

The last day of February, the 28th, or the 29th during a leap year is World Rare Disease Day and this day has been designated to help bring awareness to rare diseases as well as the impact they have on patients and their lives. Patients and family members are open to trying anything that might help.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

SpeedWeed

AUGUST 6, 2021

Saunders’ condition worsened at age 19. Today, Saunders’ medical conditions include ruptured discs in the back and spondylosis, a degenerative disc disease. Saunders sought out cannabis to treat her growing list of pains and medical conditions. The first source of cannabis was the illicit market. Courtesy of Katree Saunders.

Patients 65

Patients Conditions Treatment Therapy 65

Cannabis Law Report

JUNE 2, 2021

TOCC, which is Texas’s only medical cannabis producer with its headquarters in the state, provides thousands of patients across Texas with high-quality medical cannabis to treat chronic or severe conditions as part of the Texas Compassionate Use Program. in New York City and Asia-Pacific.

Advocacy 75

Advocacy Media Programs Cultivation 75

Veriheal

OCTOBER 27, 2020

Robert started his career with the NYPD back in 2008. In 2017 Robert was diagnosed with a condition that affects millions of Americans each year called depression. This is a point when a patient, human being, free American should have the right to access alternative legal medicines to dangerous prescription drugs.

Chronic Pain 117

Chronic Pain Cannabis Conditions Medicine 117

Cannabis Law Report

AUGUST 19, 2021

Licensing Agreement with TerrAscend will provide New Jersey with access to Cookies branded products. The parties entered into a multi-year deal under which TerrAscend will be the sole cultivator and manufacturer of Cookies branded products in New Jersey, subject to certain conditions and regulatory approval. BOONTON, N.J.–(BUSINESS

Cultivation 105

Cultivation Seed-To-Sale Conditions Business 105

SpeedWeed

AUGUST 10, 2021

Saunders’ condition worsened at age 19. Today, Saunders’ medical conditions include ruptured discs in the back and spondylosis, a degenerative disc disease. Saunders sought out cannabis to treat her growing list of pains and medical conditions. The first source of cannabis was the illicit market. Courtesy of Katree Saunders.

Patients 53

Patients Conditions Treatment Therapy 53

Cannabis Law Report

JULY 24, 2022

The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Nevertheless, the regulatory hurdles for researchers and patients are still extremely high. A total of 170 patients were treated under these licenses. Limited Medical Use”.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Green Relief

FEBRUARY 20, 2018

I was first introduced to the topic of Epigenetics in 2008 at a business conference in Florida, and as a medical professional I was immediately intrigued. Using genetic information to formulate a unique cannabis blend can decrease the “trial and error” phase upon starting cannabis, and provide more consistency in improving patient outcomes.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Green Relief

FEBRUARY 19, 2018

I was first introduced to the topic of Epigenetics in 2008 at a business conference in Florida, and as a medical professional I was immediately intrigued. Using genetic information to formulate a unique cannabis blend can decrease the “trial and error” phase upon starting cannabis, and provide more consistency in improving patient outcomes.

Therapy 40

Therapy Cannabinoids Terpenes Pharmaceutical 40

NORML

DECEMBER 10, 2019

From 2008 to 2016, Russell served as a state representative in Maine’s government. That can really hurt patients, especially if people grow normally for medical, and suddenly they want to grow high-THC for adult-use. They may stop growing the type of products that medical patients need. You have to do it state by state.

Legalization 115

Legalization Legislation Education Programs 115

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

JULY 31, 2019

For example, Arizona, [18] Connecticut, [19] Delaware, [20] Illinois, [21] Minnesota, [22] Nevada, [23] New York, [24] and Rhode Island [25] have statutes expressly prohibiting employers from discriminating against employees based on their status as medical marijuana patients. 812(b)(1). [5] Health and Safety Code § 11362.5. [7]

Law 40

Law Legalization Marijuana Policy 40

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 25, 2022

We see a lot of people out there who are suffering, and we’re determined to bring these therapies into the medical system so psychiatrists can use them with their patients,” Peter says. That would, of course, be ethically and scientifically inappropriate.” MMA says a “breach was innocently made”.

Medicine 52

Medicine Therapy Research and Development Business 52

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only.

THC 98

THC Research and Development Cannabinoids CBD 98

SMPL

MAY 26, 2020

Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

DECEMBER 8, 2021

By sufficiently moving the needle on public opinion, NORML aims to legalize the responsible use of marijuana by adults, and subsequently ensure access to products that are safe, convenient, and affordable. To hear more of JM’s thoughts on the importance of small victories, how to build momentum, and patient rights, tune in today!

Access 81

Access Policy Patients Cannabis 81

SpeedWeed

FEBRUARY 19, 2021

Both eyes of the patient are to be washed with it in the morning.”. Aleff, 1982/2008). 3000 years under favorable conditions. Furthermore, it has recently been shown that in Southern Africa a nicotine containing plant (Nicotiana Africana) occurs, which may have been accessible to ancient Egyptians.

Research and Development 52

Research and Development Cannabis Hemp Concentrates 52

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. She primarily works with plant substances to find drug treatments for neurological conditions. in/carhart-harris-robin-19112542/ [link]. David Nutt. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 29, 2019

Dr. Wakshlag and ElleVet are currently conducting additional clinical trials to demonstrate the efficacy of ElleVet hemp CBD/CBDA in other important conditions. The population we used in our investigation was representative of dogs presenting in a clinical setting for management of OA and represents the typical OA patient.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

MARCH 25, 2019

Permits the distribution of medicinal marihuana only to hospitals and pharmacies registered to dispense Schedule II controlled substances for the purposes of treating glaucoma or the nausea of cancer patients or research approved under the Federal Food, Drug, and Cosmetic Act.”. [ii] 15, 2008 , 122 Stat. 2003, 2004, 2007, 2008, Nov.

Banking 45

Banking Law Marijuana State Laws 45

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana 213

Marijuana Legalization Programs Oil 213